22m
Needham analyst Joseph Stringer maintained a Buy rating on Annexon Biosciences (ANNX – Research Report) today and set a price target of ...
It’s another big day for Mesoblast Ltd (ASX: MSB) shares. Here’s why the ASX biotech stock is making news on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback